NASDAQ · PHARMACEUTICAL PREPARATIONS · SMALL CAP
Phathom Pharmaceuticals, Inc. PHAT
8 fiscal years on record · USD · FY2025 reported · SEC filings only
Growth
USD 175.1M
Revenue, FY2025 · full 8-year series below
Revenue $M
Net income $M
FY2025 · Revenue 175.1 · Net income -221.2
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−126 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating -91.4% · Net -126.3%
ROE
FY2021 · ROE -108.0%
The 8-year record
8 fiscal years
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.2 | 0.1 | 0.0 | 0.0 | · | · | · | · |
| Operating income $B | −0.2 | −0.3 | −0.2 | −0.2 | −0.1 | −0.1 | −0.1 | −0.0 |
| EBITDA $B | −0.2 | −0.3 | −0.2 | −0.2 | −0.1 | −0.1 | −0.1 | −0.0 |
| Income tax $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | −0.2 | −0.3 | −0.2 | −0.2 | −0.1 | −0.1 | −0.3 | −0.0 |
| Free cash flow $B | −0.2 | −0.3 | −0.1 | −0.1 | −0.1 | −0.1 | −0.0 | · |
| EPS, diluted $ | −3.03 | −5.29 | −3.93 | −5.05 | −3.89 | −3.88 | −22.45 | −0.21 |
| Dividend / sh $ | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · |
| ROE % | · | · | · | · | −108.0 | −61.1 | −225.1 | · |
| Shares out B | 0.07 | 0.07 | 0.06 | 0.04 | 0.03 | 0.03 | 0.02 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 36 reconciliationsAUDITED
Reconciled in 8 of 19 fiscal years. 59 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityPharmaceutical Preparations
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2018